Form 8-K

8-K — Silo Pharma, Inc.

Accession: 0001213900-26-039352

Filed: 2026-04-02

Period: 2026-03-30

CIK: 0001514183

SIC: 2834 (PHARMACEUTICAL PREPARATIONS)

Item: Entry into a Material Definitive Agreement

Item: Unregistered Sales of Equity Securities

Item: Financial Statements and Exhibits

Documents

8-K — ea0284319-8k_silo.htm (Primary)

EX-10.1 — ASSET PURCHASE AGREEMENT, DATED MARCH 31, 2026, BETWEEN THE COMPANY AND MANY ADS INC (ea028431901ex10-1.htm)

XML — IDEA: XBRL DOCUMENT (R1.htm)

8-K — CURRENT REPORT

8-K (Primary)

Filename: ea0284319-8k_silo.htm · Sequence: 1

false

0001514183

2026-03-30

iso4217:USD

xbrli:shares

iso4217:USD

xbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of The Securities

Exchange Act of 1934

Date of Report (Date of earliest event reported):

March 30, 2026

Silo Pharma, Inc.

(Exact name of registrant as specified in its charter)

Nevada

001-41512

27-3046338

(State or other jurisdiction

of incorporation)

(Commission File Number)

(IRS Employer

Identification No.)

677 N. Washington Boulevard

Sarasota, FL

34236

(Address of principal executive offices)

(Zip Code)

Registrant’s telephone number, including

area code: (718) 400-9031

N/A

(Former name or former address, if changed since

last report)

Check the appropriate box below if the Form 8-K

filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see

General Instruction A.2. below):

☐

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Rule 12(b) of

the Act:

Title of each class

Trading Symbol(s)

Name of exchange on which registered

Common Stock, par value $0.0001 per share

SILO

The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant

is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the

Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check

mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting

standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 1.01 Entry into

a Material Definitive Agreement.

On July 29, 2025, Silo Pharma, Inc. (the “Company”)

entered into an asset purchase agreement (the “Agreement”) with Many Ads Inc. (the “Seller”). Pursuant to the

Agreement, the Seller agreed to sell, and the Company agreed to purchase, certain software of the web-based application currently marketed

as “QwikAgents” and the domain names qwikagents.com, qwikagents.ai, and qwikagents.co (the “Purchased Assets”).

In consideration for the Purchased Assets, the

Company issued to the Seller, 2,100,000 shares of its common stock, par value $0.0001 per share (the “Shares”). The Agreement

contains certain representations, warranties and covenants of the parties that are customary for agreements of its type. In addition,

the Seller agreed to indemnify the Company for any misrepresentation or breach under the Agreement, infringement of any third-party right

by any portion of the software and any acts of gross negligence, fraud or intentional misconduct by the Seller.

The foregoing summary does not purport to be complete

and is qualified in its entirety by reference to the Agreement, which will be filed as an exhibit to this Current Report on Form 8-K and

incorporated herein by reference.

Item 3.02 Unregistered Sales of Equity Securities.

The information set forth under Item 1.01 is incorporated

herein by reference.

The offer and sale to the Seller of the Shares

was made in reliance upon Section 4(a)(2) under the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits.

Exhibit

Description

10.1

Asset Purchase Agreement, dated March 31, 2026, between the Company and Many Ads Inc..

104

Cover Page Interactive Data File (embedded within the Inline XBRL document).

SIGNATURES

Pursuant to the requirements of the Securities

Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

SILO PHARMA, INC.

Date: April 2, 2026

By:

/s/ Eric Weisblum

Eric Weisblum

Chief Executive Officer

EX-10.1 — ASSET PURCHASE AGREEMENT, DATED MARCH 31, 2026, BETWEEN THE COMPANY AND MANY ADS INC

EX-10.1

Filename: ea028431901ex10-1.htm · Sequence: 2

Exhibit 10.1

ASSET PURCHASE AGREEMENT

THIS ASSET PURCHASE AGREEMENT (this “Agreement”)

is made between Many Ads Inc. a Florida corporation (“QwikAgents”) (the “Assignor”), and SILO

PHARMA. INC., a Nevada corporation (“Assignee”), and is effective as of the date of the last signature below (the

“Effective Date”).

WHEREAS, Assignor has developed

the Software (as defined herein), and exclusively owns all right, title, and interest in the domain names qwikagents.com, qwikagents.ai,

and qwikagents.co (the "Domain Names") and is the registrant of the Domain Name registered at namecheap.com (the “Registrar”),

all as identified more fully on Exhibit A; and

WHEREAS, Assignor has agreed

to sell and convey to Assignee, and Assignee has agreed to purchase, the Software and Domain Names on the terms and conditions set forth

below.

NOW THEREFORE, in consideration

of these premises and the Parties’ respective covenants and obligations set forth below, the Parties agree as follows:

Definitions.

a. “Confidential Information” means the Software and all related data, documentation,

materials and know-how.

b. “Intellectual Property Rights” means, in every jurisdiction worldwide, all (i) copyrights

of any nature (including without limitation, all rights to register, commercialize, exploit, reproduce, copy, distribute, publicly perform

and display, synchronize, prepare derivative works from, adapt, license and assign), and all other intellectual property rights, proprietary

rights and legal protections; (ii) registrations, renewals, extensions, reversions and restorations of any such rights; (iii) income,

royalties, damages and payments, now or later due or payable, with respect to any such rights; and (iv) claims and causes of action, in

law or in equity, for past, present or future infringement or misappropriation.

c. “Knowledge” means the actual knowledge of Assignor after

reasonable inquiry regarding such particular fact or other matter.

d. “Object Code” means the fully compiled version of the Software that can be executed

by a computer and used by an end user without further compilation.

e. “Open Source Software” means any software component that is distributed as “free

software,” “open source software,” or pursuant to any open source copyright license agreement, including the GNU General

Public License, GNU Library or Lesser Public License, GNU Affero General Public License, MIT License, Apache License, Artistic License

and BSD Licenses, or any other obligation, restriction or license agreement that substantially conforms to the Open Source Definition

(opensource.org/osd) as prescribed by the Open Source Initiative or otherwise controls the distribution and use of one or more software

components or that may require disclosure or licensing to any third party of any source code with which such software component is used

or compiled.

f. “Purchase Price” means two million one hundred thousand (2,100,000) shares of common

stock, par value $0.0001 per share, of the Assignee.

g. “Software” means that certain software comprising the entirety of the code for the

design, appearance, content, features and functionality of the web- based application currently marketed as “qwikagents.com,”

together with all related documentation, and all derivative works, updates, improvements, modifications and enhancements made by or on

behalf of any Assignor.

“Source Code” means

the human-readable version of the Software that can be compiled into Object Code.

Sale and Assignment.

a. Software.

In consideration of the Purchase Price, Assignor irrevocably sells, assigns, grants, conveys and transfers to Assignee and its successors

and assigns, without any reservation whatsoever and without further consideration, and Assignee hereby accepts, all right, title and interest

throughout the world, including all Intellectual Property Rights that Assignor may now have or later acquire, in and to the Software.

b. Domain

Names. In consideration of the Purchase Price, Assignor hereby sells, assigns, transfers, and conveys to Assignee, and

Assignee hereby accepts and otherwise acquires, all of Assignor’s past, present and future rights, title, privileges, benefits,

proceeds and interest in and to the Domain Names, including the current registration thereof with Registrar.

3. Purchase

Price. On the Effective Date, Assignee shall deliver to the Assignor a certificate (or book entry confirmation of registration and

issuance) evidencing the Purchase Price in full satisfaction of all amounts owed by Assignee in connection with this Agreement.

Delivery.

a. Software.

On the Effective Date, Assignor shall deliver to Assignee one digital copy of all Software (including Source Code and Object Code, as

applicable), as it exists as of the Effective Date, in a format that is (a) readable and usable by a programmer of ordinary skill and

contain all information, in human readable form, that such a programmer would need in order to understand, compile, build, maintain, modify,

correct and operate the Software, including any integrated Open Source Software, without undue experimentation, difficulty or expense;

(b) not password protected, encrypted or subject to other security measures that might impede Assignee’s ability to access or use

the Software; (c) accurately labeled; and (d) in media and formats that are fully operable in and compatible with Assignee’s operating

environment and technology systems.

b. Domain

Names. On the Effective Date, the Domain Name will be transferred to the control of the Assignee as soon as the Registrar allows the

domain name to be transferred to Assignee.

Representations and Warranties.

a. Software.

Assignor represents and warrants that the Software (a) was developed by Assignor and/or third parties acting on Assignor’s behalf,

and Assignor owns or otherwise has sufficient rights (by assignment, work-made-for-hire agreement, or license) to transfer the Software

and the Intellectual Property Rights being conveyed under this Agreement; (b) contains no harmful or malicious code; (c) to the best of

Assignor’s knowledge, does not (i) violate any law, rule or regulation in any material respect and (ii) infringe any third-party

Intellectual Property Rights; and (d) includes Open Source Software components. Assignor represents and warrants that: (i) all material

Open Source Software used in the Software and all direct package dependencies listed in Assignor’s package manifests are identified

on Exhibit B; (ii) Assignor’s use of such Open Source Software is in compliance in all material respects with the applicable license

terms; and (iii) to the best of Assignor’s knowledge, except as set forth on Exhibit B, the Software does not include any

Open Source Software in a manner that would require disclosure or distribution of the Source Code of the Software (other than such Open

Source Software components themselves) or grant any third party a license to the Software. For clarity, Exhibit B discloses one LGPL-licensed

optional, Windows-only native binary dependency associated with image optimization tooling; Assignor has not modified such LGPL component.

Assignor further represents and warrants that Assignor (e) is the exclusive author of the Software and the exclusive owner of all Intellectual

Property Rights in and to the Software, free and clear of liens, security interests and other encumbrances; (f) is in actual possession

of and has exclusive control over a complete and correct copy of the Software; (g) has not caused or allowed any third party to have a

license to any Intellectual Property Rights in or to the Software; (h) has not registered or applied for registration of any portion of

the Software, or any Intellectual Property Rights in or to any portion of the Software, or any patent related to any portion of the Software,

in any jurisdiction; (i) has not either taken any action or failed to take any action that has encumbered the Software or that may reasonably

be expected to impair or prejudice Assignee’s rights in the Software; and (j) has full right, power and authority to execute this

Agreement.

b. Domain

Names. In addition, Assignor represents and warrants that (a) it is the sole registrant and owner of all right, title, and interest

in and to the Domain Names; (b) it owns the Domain Names free and clear of any valid or registered liens, security interests, or other

encumbrances; (c) the registration agreement for the Domain Names are in full force and effect, and all registration fees are paid in

full for registration through the Effective Date and Assignor has at all times been and remains in full compliance with such registration

agreement; (d) its registration, ownership, and use of the Domain Names has not been subject to any action that has been instituted, settled,

or threatened alleging any infringement, misappropriation, dilution, or other violation of intellectual property rights, and the Assignor

has not received any communication asserting any such allegations; and (e) it does not own any other domain names or registrations therefor

that include the terms “qwikagents” or any colorable imitations thereof.

c. Assignee’s

Representations. The execution, delivery and performance by Assignee of the Agreement, and the consummation by it of the transactions

contemplated hereby, are within its corporate powers, and have been duly authorized by all necessary corporate action on the part of Assignee,

and no other action on the part of Assignee is necessary to authorize this Agreement or the consummation of the transactions contemplated

hereby. Assignee has duly executed this Agreement, and assuming the due authorization, execution and delivery of this Agreement by the

Assignor, this Agreement constitutes a valid and binding agreement of Assignee enforceable against it in accordance with its terms, subject

to (i) applicable bankruptcy, insolvency, fraudulent transfer, reorganization, moratorium and other laws affecting creditors’ rights

generally and (ii) general principles of equity, including applicable laws relating to specific performance, injunctive relief and other

equitable remedies.

d. Except

for the representations and warranties expressly set forth in this Agreement and the documents executed by Assignor and delivered to Assignee,

Assignor has not made any other representations or warranties of any kind upon which Assignee is relying as to any matters concerning

the Intellectual Property Rights in and to the Software.

Obligations of the Parties.

a. Obligations

of Assignee.

i. Assignee shall promptly transfer the domain names once the domains have been unlocked and the authorization

code for transfers has been provided to Assignee by the Assignor.

ii. Assignee shall take all steps necessary to deliver the Purchase Price to Assignor as contemplated by this Agreement.

b. Obligations

of Assignor.

iii. Assignor shall cooperate fully to effectuate the transfer of the domain names to the Assignee once the Purchase Price has been delivered.

iv. Assignor shall take all steps necessary to deliver the Domain Names to Assignee as contemplated by this Agreement.

v. Assignor agrees that it will not register or facilitate or encourage the registration of any other domain name that includes the terms

“qwikagents” or any colorable imitations thereof.

vi. Assignor agrees that it will not hereafter challenge Assignee’s or any successor of Assignee’s ownership or use of the

Domain Names or any other domain name, trademark, or service mark that includes the terms “qwikagents” or any colorable imitations

thereof.

7. Further

Assurance. Each party hereto shall cooperate fully and promptly with the other party hereto, and shall execute and deliver all such

other documents, and shall take all such further action as may be necessary or appropriate to consummate the transactions contemplated

hereby, including, the transfer of the Intellectual Property Rights in and to the Software to the Assignee and the transfer of the Purchase

Price to the Assignor.

8. Survival; Indemnity. (a) All representations

and warranties contained in this Agreement and in any certificate or other document delivered pursuant to this Agreement, shall survive

the Closing for a period of six (6) months from the Effective Date. No action, demand or claim for indemnification may be asserted against

either Party for breach of any representation, warranty, covenant or agreement contained herein, unless written notice of such action,

demand or claim is received by such party describing in reasonable detail the facts and circumstances with respect to the subject matter

of such claim on or prior to the date on which the representation, warranty, covenant or agreement on which such action, demand or claim

is based ceases to survive as set forth in this Section 8.

(b) Assignor

shall indemnify, defend and hold harmless Assignee and its parent, subsidiaries, directors, officers, employees, agents, successors and

assigns from and against all liability, losses, damages, costs and expenses (including reasonable legal fees) arising out of any demand,

claim, judgment, order or proceeding related to (a) any misrepresentation, or breach of warranty or this Agreement, by any of Assignor;

(b) infringement of any third-party right by any portion of the Software; or (c) any acts of gross negligence, fraud or intentional misconduct

by any of Assignor. Assignor’s aggregate liability under this Agreement shall not exceed the Purchase Price (the “Liability

Cap”). Notwithstanding the foregoing, the Liability Cap shall apply to losses arising out of or based on Assignor’s

fraud.

9. Confidentiality.

Assignor shall maintain the existence and terms of this Agreement in strict confidence and shall not disclose such terms to any third

party, except to legal counsel for the purpose of obtaining advice regarding this Agreement or otherwise as expressly required by law.

Assignor shall not use the Confidential Information, and shall not disclose the Confidential Information without Assignee’s prior

express, written consent. Promptly upon Assignee’s request, Assignor shall deliver or destroy, as instructed, all of the Confidential

Information.

10. Entire

Agreement; Amendments. This Agreement contains the complete and final agreement between the Parties regarding the subject matter of

this Agreement. No amendment to this Agreement is valid unless made in writing and signed by all Parties to this Agreement.

11. No

Waiver. No failure or delay by either Party in enforcing an obligation or exercising a right or remedy will be deemed a waiver of

that obligation, right or remedy by that Party. No waiver by either Party of a right or remedy with respect to the other Party’s

breach of a term of this Agreement will be deemed a waiver of a right or remedy with respect to any other breach of any other term of

this Agreement. No waiver of a right with respect to a particular obligation in one circumstance will prevent a Party from subsequently

requiring compliance with that obligation on other occasions. The doctrine of affirmation by implied election will not apply.

12. Severability.

If any portion of this Agreement is found to be invalid or unenforceable by any court of competent jurisdiction, the Parties shall

negotiate in good faith to amend the invalid or unenforceable portion in accordance with the Parties’ mutual intent. If no agreement

is reached within five calendar days, the invalid or unenforceable portion, as identified as narrowly as possible, will be stricken from

the Agreement, and such action will not affect in any respect whatsoever the validity or enforceability of the remainder of the Agreement.

13. Governing

Law. This Agreement is governed by and will be construed in accordance with the laws of the State of Nevada, without giving effect

to any choice of law or conflict of laws principles.

14. General.

This Agreement is binding upon and shall inure to the benefit of the Parties and their respective successors and assigns. This Agreement

is the result of arms-length, good faith negotiations and each Party had every opportunity to review the Agreement with its own counsel.

Any rule of construction that a contract is to be construed against the drafter will not apply. This Agreement may be executed in counterparts,

each of which will be deemed an original, but all of which together will be deemed one and the same agreement.

[Signatures on next page]

To evidence the Parties’

agreement, the Parties have executed this Agreement below as of its Effective Date.

ASSIGNOR:

ASSIGNEE:

MANY ADS, INC.

SILO PHARMA, INC.

By:

/s/ Menachem Ben-Or

By:

/s/ Eric Weisblum

(sign)

(Sign)

(print)

Menachem Ben-Or

(print)

Eric Weisblum

Its:

Managing Director

Its:

CEO

Date:

3/30/26

Date:

3/30/26

EXHIBIT A

THE SOFTWARE

Software Name and Description

“QwikAgents” web-based application and related services, consisting of: (i) a Next.js/React portal located at apps/portal, including authentication, billing/subscriptions, database access and API integrations; and (ii) an MCP server located at packages/mcp-server implementing the Model Context Protocol and related tooling, together with associated configuration, schema/migrations, and documentation, in each case as existing as of the Effective Date.

Author Full Legal Name(s)

Many Ads Inc.

Author Nationality or Domicile

Florida

Year Completed

2026

Date of First Publication

Nation of First Publication

DOMAIN NAMES

Qwikagents.com

qwikagents.ai

qwikagents.co

OPEN SOURCE SOFTWARE

A. Statement of Scope:

The parties acknowledge that the Software is developed using

Open Source Software. This Exhibit B identifies (i) direct package dependencies listed in Assignor’s package manifests and (ii)

other material Open Source Software components, and includes an informational summary of a transitive dependency license scan. This Exhibit

B is not intended to be an exhaustive listing of all transitive or indirect dependencies pulled in by package managers.

B. Direct Dependencies (Package Manifests)

B.1 Portal (apps/portal) — Production

Dependencies (Direct)

next — 16.1.6 — React framework (App Router)

react — 19.2.3 — UI library

react-dom — 19.2.3 — React DOM renderer

@clerk/nextjs — ^6.37.2 — Authentication

stripe — ^20.3.0 — Billing / subscriptions

@prisma/client — ^7.3.0 — Database ORM

@prisma/adapter-pg — ^7.3.0 — PostgreSQL adapter

prisma — ^7.3.0 — Schema / migrations

pg — ^8.18.0 — PostgreSQL driver

@anthropic-ai/sdk — ^0.73.0 — Anthropic API client

@sentry/nextjs — ^10.38.0 — Error tracking

@upstash/redis — ^1.36.2 — Rate limiting store

@upstash/ratelimit — ^2.0.8 — Rate limiter

@upstash/qstash — ^2.9.0 — Async message delivery

resend — ^6.9.2 — Transactional email

svix — ^1.84.1 — Webhook delivery

@scalar/api-reference — ^1.44.20 — API docs UI

@monaco-editor/react — ^4.7.0 — Prompt editor

swr — ^2.4.0 — Data fetching / caching

radix-ui — ^1.4.3 — Accessible UI primitives

lucide-react — ^0.563.0 — Icon library

tailwind-merge — ^3.4.0 — Tailwind class merging

class-variance-authority — ^0.7.1 — Component variants

clsx — ^2.1.1 — Class name utility

date-fns — ^4.1.0 — Date formatting

react-hook-form — ^7.71.1 — Form handling

zod — ^4.3.6 — Schema validation

B.2 Portal (apps/portal) — Dev Dependencies

(Direct)

typescript — ^5 — Type checking

@types/node — ^20 — Node type defs

@types/react — ^19 — React type defs

@types/react-dom — ^19 — React DOM type defs

@types/pg — ^8.16.0 — PostgreSQL type defs

eslint — ^9 — Linter

eslint-config-next — 16.1.6 — Next.js ESLint rules

eslint-plugin-unused-imports — ^4.4.1 — Dead import detection

tailwindcss — ^4 — CSS framework

@tailwindcss/postcss — ^4 — PostCSS plugin

tw-animate-css — ^1.4.0 — Animation utilities

@playwright/test — ^1.58.1 — E2E testing

dotenv — ^17.2.3 — Env file loading

B.3 MCP Server (packages/mcp-server) — Production

Dependencies (Direct)

@modelcontextprotocol/sdk — ^1.26.0 — MCP protocol

implementation

zod — ^4.3.6 — Schema validation

commander — ^12.1.0 — CLI argument parsing

chalk — ^5.3.0 — Terminal colors

C. Summary License Audit (Informational)

Assignor performed a license scan of third-party packages present in node_modules as of the Effective Date and identified 893 packages

in total (including transitive dependencies). License counts: MIT (729), Apache-2.0 (96), ISC (26), BSD-2-Clause (13), BSD-3-Clause (9),

BlueOak-1.0.0 (3), FSL-1.1-MIT (2), MPL-2.0 (2), Unlicense (2), Other (4), UNKNOWN (3). GPL/LGPL/AGPL: 1 package found, disclosed below.

D. Copyleft / LGPL Disclosures (if any)

@img/sharp-win32-x64 — License: Apache-2.0 AND LGPL-3.0-or-later

Purpose: Windows-only native binary used by Next.js image optimization tooling (libvips under the hood).

Nature: Optional dependency; Windows-only.

Status: To Assignor’s Knowledge, this package is not shipped as part of Assignee’s production deployment as configured as

of the Effective Date.

Modifications: Assignor has not modified libvips or the LGPL-licensed components contained therein.

E. UNKNOWN License Items

The license scan identified three (3) packages with license reported as “UNKNOWN.” Assignor will, upon Assignee’s written

request made within thirty (30) days following the Effective Date, use commercially reasonable efforts to identify the applicable license

terms for such items or replace/remove such items in the Software where reasonably practicable.

F. Copyleft / Source-Disclosure Notes

To Assignor’s Knowledge, except as disclosed in this Exhibit B, the Software is not distributed in a manner that triggers any requirement

to disclose or distribute the Source Code of the Software (other than Open Source Software components themselves) or to license the Software

to any third party under the terms of any copyleft license (e.g., GPL, LGPL, AGPL).

XML — IDEA: XBRL DOCUMENT

XML

Filename: R1.htm · Sequence: 7

v3.26.1

Cover

Mar. 30, 2026

Cover [Abstract]

Document Type

8-K

Amendment Flag

false

Document Period End Date

Mar. 30, 2026

Entity File Number

001-41512

Entity Registrant Name

Silo Pharma, Inc.

Entity Central Index Key

0001514183

Entity Tax Identification Number

27-3046338

Entity Incorporation, State or Country Code

Entity Address, Address Line One

677 N. Washington Boulevard

Entity Address, City or Town

Sarasota

Entity Address, State or Province

Entity Address, Postal Zip Code

34236

City Area Code

718

Local Phone Number

400-9031

Written Communications

false

Soliciting Material

false

Pre-commencement Tender Offer

false

Pre-commencement Issuer Tender Offer

false

Title of 12(b) Security

Common Stock, par value $0.0001 per share

Trading Symbol

SILO

Security Exchange Name

NASDAQ

Entity Emerging Growth Company

false

- Definition

Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.

+ References

No definition available.

+ Details

Name:

dei_AmendmentFlag

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Area code of city

+ References

No definition available.

+ Details

Name:

dei_CityAreaCode

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Cover page.

+ References

No definition available.

+ Details

Name:

dei_CoverAbstract

Namespace Prefix:

dei_

Data Type:

xbrli:stringItemType

Balance Type:

Period Type:

duration

- Definition

For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.

+ References

No definition available.

+ Details

Name:

dei_DocumentPeriodEndDate

Namespace Prefix:

dei_

Data Type:

xbrli:dateItemType

Balance Type:

Period Type:

duration

- Definition

The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.

+ References

No definition available.

+ Details

Name:

dei_DocumentType

Namespace Prefix:

dei_

Data Type:

dei:submissionTypeItemType

Balance Type:

Period Type:

duration

- Definition

Address Line 1 such as Attn, Building Name, Street Name

+ References

No definition available.

+ Details

Name:

dei_EntityAddressAddressLine1

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Name of the City or Town

+ References

No definition available.

+ Details

Name:

dei_EntityAddressCityOrTown

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Code for the postal or zip code

+ References

No definition available.

+ Details

Name:

dei_EntityAddressPostalZipCode

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Name of the state or province.

+ References

No definition available.

+ Details

Name:

dei_EntityAddressStateOrProvince

Namespace Prefix:

dei_

Data Type:

dei:stateOrProvinceItemType

Balance Type:

Period Type:

duration

- Definition

A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityCentralIndexKey

Namespace Prefix:

dei_

Data Type:

dei:centralIndexKeyItemType

Balance Type:

Period Type:

duration

- Definition

Indicate if registrant meets the emerging growth company criteria.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityEmergingGrowthCompany

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.

+ References

No definition available.

+ Details

Name:

dei_EntityFileNumber

Namespace Prefix:

dei_

Data Type:

dei:fileNumberItemType

Balance Type:

Period Type:

duration

- Definition

Two-character EDGAR code representing the state or country of incorporation.

+ References

No definition available.

+ Details

Name:

dei_EntityIncorporationStateCountryCode

Namespace Prefix:

dei_

Data Type:

dei:edgarStateCountryItemType

Balance Type:

Period Type:

duration

- Definition

The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityRegistrantName

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityTaxIdentificationNumber

Namespace Prefix:

dei_

Data Type:

dei:employerIdItemType

Balance Type:

Period Type:

duration

- Definition

Local phone number for entity.

+ References

No definition available.

+ Details

Name:

dei_LocalPhoneNumber

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 13e

-Subsection 4c

+ Details

Name:

dei_PreCommencementIssuerTenderOffer

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 14d

-Subsection 2b

+ Details

Name:

dei_PreCommencementTenderOffer

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Title of a 12(b) registered security.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b

+ Details

Name:

dei_Security12bTitle

Namespace Prefix:

dei_

Data Type:

dei:securityTitleItemType

Balance Type:

Period Type:

duration

- Definition

Name of the Exchange on which a security is registered.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection d1-1

+ Details

Name:

dei_SecurityExchangeName

Namespace Prefix:

dei_

Data Type:

dei:edgarExchangeCodeItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 14a

-Subsection 12

+ Details

Name:

dei_SolicitingMaterial

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Trading symbol of an instrument as listed on an exchange.

+ References

No definition available.

+ Details

Name:

dei_TradingSymbol

Namespace Prefix:

dei_

Data Type:

dei:tradingSymbolItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Securities Act

-Number 230

-Section 425

+ Details

Name:

dei_WrittenCommunications

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration